The Asia Pacific RNA Based Therapeutic Market would witness market growth of 15.6% CAGR during the forecast period (2021-2027).
RNA-based biopharmaceuticals, which include vaccines and treatments, are a relatively new class of medicine. These biopharmaceuticals are preventive medicines that are used to treat a variety of rare and chronic diseases, such as cardiovascular disease, TB, diabetes, and cancer. The primary goal of RNA therapies is to develop an effective treatment for rare diseases and other unmet medical needs. This is a research-based area, and technological advancements are expected to increase the global RNA-based medicines and vaccines market during the forecasting period.
In addition, in upcoming years, the development of numerous potential technologies such as RNA interference technology, SMaRT technology, and antisense technology is anticipated to offer significant growth possibilities for the worldwide RNA-based therapies and vaccines market.
The market for RNA-based therapeutics and vaccines in Japan is the largest in the Asia Pacific, owing to the growing importance of customized medicine. In addition, the high frequency of infectious diseases in the Asia Pacific is likely to create significant potential for RNA-based therapeutics and vaccines. The rising population of the countries that comes under APAC such as India and China, plays a major role in accelerating the demand for RNA-based therapeutic across APAC.
In addition, these countries are under a developing phase and going under constant enhancements and developments rapidly. With these developments, the healthcare infrastructure of the region is constantly growing stronger.
The China market dominated the Asia Pacific RNA Based Therapeutic Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $685.8 million by 2027. The Japan market is exhibiting a CAGR of 15% during (2021 - 2027). Additionally, The India market would witness CAGR of 16.4% during (2021 - 2027).
Based on Type, the market is segmented into RNA Antisense and RNA Interference (RNAi). Based on Application, the market is segmented into Genetic disorders and Auto immune disorders. Based on End User, the market is segmented into Research Institutes and Hospitals & Clinics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide RNA Based Therapeutic Market is Projected to reach USD 11.4 Billion by 2027, at a CAGR of 15.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Arbutus Biopharma Corporation, Arrowhead Pharmaceuticals, Inc., Benitec Biopharma, Inc., Alnylam Pharmaceuticals, Inc., Sanofi S.A. (Sanofi Genzyme), Biogen, Inc., Gradalis, Inc., Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., and Silence Therapeutics Plc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- RNA Antisense
- RNA Interference (RNAi)
By Application
- Genetic disorders
- Auto immune disorders
By End User
- Research Institutes
- Hospitals & Clinics
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Arbutus Biopharma Corporation
- Arrowhead Pharmaceuticals, Inc.
- Benitec Biopharma, Inc.
- Alnylam Pharmaceuticals, Inc.
- Sanofi S.A. (Sanofi Genzyme)
- Biogen, Inc.
- Gradalis, Inc.
- Ionis Pharmaceuticals, Inc.
- Sarepta Therapeutics, Inc.
- Silence Therapeutics Plc
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific RNA Based Therapeutic Market, by Type
1.4.2 Asia Pacific RNA Based Therapeutic Market, by Application
1.4.3 Asia Pacific RNA Based Therapeutic Market, by End User
1.4.4 Asia Pacific RNA Based Therapeutic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2017, Apr – 2022, Jan) Leading Players
Chapter 4. Asia Pacific RNA Based Therapeutic Market by Type
4.1 Asia Pacific RNA Antisense Market by Country
4.2 Asia Pacific RNA Interference (RNAi) Market by Country
Chapter 5. Asia Pacific RNA Based Therapeutic Market by Application
5.1 Asia Pacific Genetic disorders Market by Country
5.2 Asia Pacific Auto immune disorders Market by Country
Chapter 6. Asia Pacific RNA Based Therapeutic Market by End User
6.1 Asia Pacific Research Institutes Market by Country
6.2 Asia Pacific Hospitals & Clinics Market by Country
Chapter 7. Asia Pacific RNA Based Therapeutic Market by Country
7.1 China RNA Based Therapeutic Market
7.1.1 China RNA Based Therapeutic Market by Type
7.1.2 China RNA Based Therapeutic Market by Application
7.1.3 China RNA Based Therapeutic Market by End User
7.2 Japan RNA Based Therapeutic Market
7.2.1 Japan RNA Based Therapeutic Market by Type
7.2.2 Japan RNA Based Therapeutic Market by Application
7.2.3 Japan RNA Based Therapeutic Market by End User
7.3 India RNA Based Therapeutic Market
7.3.1 India RNA Based Therapeutic Market by Type
7.3.2 India RNA Based Therapeutic Market by Application
7.3.3 India RNA Based Therapeutic Market by End User
7.4 South Korea RNA Based Therapeutic Market
7.4.1 South Korea RNA Based Therapeutic Market by Type
7.4.2 South Korea RNA Based Therapeutic Market by Application
7.4.3 South Korea RNA Based Therapeutic Market by End User
7.5 Singapore RNA Based Therapeutic Market
7.5.1 Singapore RNA Based Therapeutic Market by Type
7.5.2 Singapore RNA Based Therapeutic Market by Application
7.5.3 Singapore RNA Based Therapeutic Market by End User
7.6 Malaysia RNA Based Therapeutic Market
7.6.1 Malaysia RNA Based Therapeutic Market by Type
7.6.2 Malaysia RNA Based Therapeutic Market by Application
7.6.3 Malaysia RNA Based Therapeutic Market by End User
7.7 Rest of Asia Pacific RNA Based Therapeutic Market
7.7.1 Rest of Asia Pacific RNA Based Therapeutic Market by Type
7.7.2 Rest of Asia Pacific RNA Based Therapeutic Market by Application
7.7.3 Rest of Asia Pacific RNA Based Therapeutic Market by End User
Chapter 8. Company Profiles
8.1 Arbutus Biopharma Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Acquisitions, Mergers and Joint Ventures:
8.2 Arrowhead Pharmaceuticals, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Benitec Biopharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expenses
8.4 Alnylam Pharmaceuticals, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Approvals and Trials:
8.5 Sanofi S.A. (Sanofi Genzyme)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Biogen, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Gradalis, Inc.
8.7.1 Company Overview
8.8 Ionis Pharmaceuticals, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Sarepta Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.9.4 Recent strategies and developments:
8.9.4.1 Partnerships, Collaborations, and Agreements:
8.10. Silence Therapeutics Plc
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– RNA Based Therapeutic Market
TABLE 4 Acquisition and Mergers– RNA Based Therapeutic Market
TABLE 5 Approvals and trials– RNA Based Therapeutic Market
TABLE 6 Asia Pacific RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 7 Asia Pacific RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 8 Asia Pacific RNA Antisense Market by Country, 2017 - 2020, USD Million
TABLE 9 Asia Pacific RNA Antisense Market by Country, 2021 - 2027, USD Million
TABLE 10 Asia Pacific RNA Interference (RNAi) Market by Country, 2017 - 2020, USD Million
TABLE 11 Asia Pacific RNA Interference (RNAi) Market by Country, 2021 - 2027, USD Million
TABLE 12 Asia Pacific RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 13 Asia Pacific RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 14 Asia Pacific Genetic disorders Market by Country, 2017 - 2020, USD Million
TABLE 15 Asia Pacific Genetic disorders Market by Country, 2021 - 2027, USD Million
TABLE 16 Asia Pacific Auto immune disorders Market by Country, 2017 - 2020, USD Million
TABLE 17 Asia Pacific Auto immune disorders Market by Country, 2021 - 2027, USD Million
TABLE 18 Asia Pacific RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 19 Asia Pacific RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 20 Asia Pacific Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 21 Asia Pacific Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 22 Asia Pacific Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 23 Asia Pacific Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 24 Asia Pacific RNA Based Therapeutic Market by Country, 2017 - 2020, USD Million
TABLE 25 Asia Pacific RNA Based Therapeutic Market by Country, 2021 - 2027, USD Million
TABLE 26 China RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 27 China RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 28 China RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 29 China RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 30 China RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 31 China RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 32 China RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 33 China RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 34 Japan RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 35 Japan RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 36 Japan RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 37 Japan RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 38 Japan RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 39 Japan RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 40 Japan RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 41 Japan RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 42 India RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 43 India RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 44 India RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 45 India RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 46 India RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 47 India RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 48 India RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 49 India RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 50 South Korea RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 51 South Korea RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 52 South Korea RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 53 South Korea RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 54 South Korea RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 55 South Korea RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 56 South Korea RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 57 South Korea RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 58 Singapore RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 59 Singapore RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 60 Singapore RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 61 Singapore RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 62 Singapore RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 63 Singapore RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 64 Singapore RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 65 Singapore RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 66 Malaysia RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 67 Malaysia RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 68 Malaysia RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 69 Malaysia RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 70 Malaysia RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 71 Malaysia RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 72 Malaysia RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 73 Malaysia RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 74 Rest of Asia Pacific RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 75 Rest of Asia Pacific RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 76 Rest of Asia Pacific RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 77 Rest of Asia Pacific RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 78 Rest of Asia Pacific RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 79 Rest of Asia Pacific RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 80 Rest of Asia Pacific RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 81 Rest of Asia Pacific RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 82 Key information – Arbutus Biopharma Corporation
TABLE 83 Key information – Arrowhead Pharmaceuticals, Inc.
TABLE 84 Key information – Benitec Biopharma, Inc.
TABLE 85 Key Information – Alnylam Pharmaceuticals, Inc.
TABLE 86 Key Information – Sanofi S.A.
TABLE 87 Key Information – Biogen, Inc.
TABLE 88 Key information – Gradalis, Inc.
TABLE 89 Key information – Ionis Pharmaceuticals, Inc.
TABLE 90 Key information – Sarepta Therapeutics, Inc.
TABLE 91 Key information – Silence Therapeutics plc
List of Figures
FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2017, Apr – 2022, Jan) Leading Players
FIG 4 Recent strategies and developments: Arbutus Biopharma Corporation
FIG 5 Recent strategies and developments: Sanofi S.A.